Deficient RPE mitochondrial energetics leads to subretinal fibrosis in age-related neovascular macular degeneration

Commun Biol. 2024 Sep 2;7(1):1075. doi: 10.1038/s42003-024-06773-7.

Abstract

Subretinal fibrosis permanently impairs the vision of patients with neovascular age-related macular degeneration. Despite emerging evidence revealing the association between disturbed metabolism in retinal pigment epithelium (RPE) and subretinal fibrosis, the underlying mechanism remains unclear. In the present study, single-cell RNA sequencing revealed, prior to subretinal fibrosis, genes in mitochondrial fatty acid oxidation are downregulated in the RPE lacking very low-density lipoprotein receptor (VLDLR), especially the rate-limiting enzyme carnitine palmitoyltransferase 1A (CPT1A). We found that overexpression of CPT1A in the RPE of Vldlr-/- mice suppresses epithelial-to-mesenchymal transition and fibrosis. Mechanistically, TGFβ2 induces fibrosis by activating a Warburg-like effect, i.e. increased glycolysis and decreased mitochondrial respiration through ERK-dependent CPT1A degradation. Moreover, VLDLR blocks the formation of the TGFβ receptor I/II complex by interacting with unglycosylated TGFβ receptor II. In conclusion, VLDLR suppresses fibrosis by attenuating TGFβ2-induced metabolic reprogramming, and CPT1A is a potential target for treating subretinal fibrosis.

MeSH terms

  • Animals
  • Carnitine O-Palmitoyltransferase* / deficiency
  • Carnitine O-Palmitoyltransferase* / genetics
  • Carnitine O-Palmitoyltransferase* / metabolism
  • Energy Metabolism
  • Epithelial-Mesenchymal Transition
  • Fibrosis*
  • Humans
  • Macular Degeneration* / genetics
  • Macular Degeneration* / metabolism
  • Macular Degeneration* / pathology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mitochondria* / metabolism
  • Mitochondria* / pathology
  • Receptors, LDL* / deficiency
  • Receptors, LDL* / genetics
  • Receptors, LDL* / metabolism
  • Retinal Pigment Epithelium* / metabolism
  • Retinal Pigment Epithelium* / pathology
  • Transforming Growth Factor beta2* / genetics
  • Transforming Growth Factor beta2* / metabolism

Substances

  • Carnitine O-Palmitoyltransferase
  • Transforming Growth Factor beta2
  • Receptors, LDL
  • VLDL receptor
  • CPT1B protein, mouse